Vapaliximab
Vapaliximab (pronounced vuh-puh-lix-ih-mab) is a monoclonal antibody designed for the treatment of autoimmune diseases. It is currently under investigation in clinical trials.
Etymology
The name "Vapaliximab" follows the World Health Organization's guidelines for the nomenclature of monoclonal antibodies. The suffix "-mab" indicates that it is a monoclonal antibody, while the infix "-lix-" suggests that it is intended for the immune system.
Usage
Vapaliximab is being studied for its potential use in treating various autoimmune diseases. Autoimmune diseases are conditions in which the body's immune system mistakenly attacks its own cells. By targeting specific components of the immune system, Vapaliximab may help to reduce this harmful response.
Related Terms
- Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
- Autoimmune Disease: A condition in which your immune system mistakenly attacks your body.
- Clinical Trial: Research studies that involve people. They test whether drugs, therapies, medical procedures, or devices are safe and effective.
- Immune System: A complex network of cells, tissues, organs, and the substances they make that helps the body fight infections and other diseases.
See Also
External links
- Medical encyclopedia article on Vapaliximab
- Wikipedia's article - Vapaliximab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski